Table 1.
Formulation | Abbreviation | Size (nm) | PDI | Zeta potential (mV) | rHBAg association (%) |
---|---|---|---|---|---|
Nanoemulsion | NE | 264 ± 10 | 0.2 | –23 ± 2 | – |
Chitosan nanocapsules | CS NCs | 456 ± 2 | 0.3 | +47 ± 2 | – |
Protamine nanocapsules | PR NCs | 274 ± 4 | 0.2 | +27 ± 4 | – |
rHBsAg-loaded protamine nanocapsules | PR NCs-rHBsAg | 358 ± 20 | 0.3 | +5 ± 4 | 74 ± 5 |
Polyarginine nanocapsules | PARG NCs | 251 ± 2 | 0.1 | +30 ± 2 | – |
rHBsAg-loaded polyarginine nanocapsules | PARG NCs-rHBsAg | 320 ± 8 | 0.3 | +15 ± 1 | 70 ± 7 |
PDI, polydispersity index; HBsAg, hepatitis B surface antigen.